SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-016771
Filing Date
2018-07-12
Accepted
2018-07-12 06:05:20
Documents
5
Period of Report
2018-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180711.htm 8-K 41654
2 EX-1.1 xene-ex11_6.htm EX-1.1 264041
3 EX-5.1 xene-ex51_7.htm EX-5.1 11607
4 GRAPHIC g201807120213141442821.jpg GRAPHIC 15580
5 GRAPHIC g201807120213141592822.jpg GRAPHIC 3119
  Complete submission text file 0001564590-18-016771.txt   344552
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 18949611
SIC: 2834 Pharmaceutical Preparations